First Episode Psychosis (FEP)
12
3
3
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (12)
Early Psychosis: Investigating Cognition
Dopamine and Insulin in Psychosis
Testing the Efficacy of the Cannabis Clinic for Patients With Psychosis (CCP) Intervention for Cannabis Use Reduction/Cessation in Patients With First Episode Psychosis (FEP)
Physical Exercise in Patients With First Psychotic Episode
California Collaborative Network to Promote Data Driven Care and Improve Outcomes in Early Psychosis
Reducing the Duration of Untreated Psychosis in the United States: The Impact of Screening and Systematic Communication
Psychoeducation Program for Family Caregivers Coordinated by an APRN
Nursing Intervention in Weight and Metabolic Syndrome Management in First-episode Psychosis (MetaKOP)
Adapted Physical Activity Program for Patients Undergoing Antipsychotic Treatment of a First Episode of Psychosis
Self-administered COgnitive Personalized Training in Early Psychosis
Use of Parent Connectors in First Episode Psychosis (FEP)
Reducing the Duration of Untreated Psychosis in the United States